Flagship explainer
How Indivior Pharmaceuticals, Inc. makes its money
Start with a dollar of revenue and follow what the filing says remains.
Honest partial: the filing did not provide a normalized tag for Research and development, Selling, general and administrative; those components are omitted, not plugged.
| Filed line | Value | % of revenue | Source |
|---|---|---|---|
| $1.2B | 100% |
| |
| Cost of revenue | $246M | 20% |
|
| $994M | 80% |
| |
| $262M | 21% |
| |
| Income before tax | $239M | 19% |
|
| Income tax | $29M | 2% |
|
| $210M | 17% |
|
Source:
- SEC filing · FY 2025Filing detailsAccession 0001628280-26-012237